Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) is the first and only U.S. FDA-approved extended-release liquid formulation of metformin…
Pharmaceuticals, Biotechnology and Life Sciences
RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) is the first and only U.S. FDA-approved extended-release liquid formulation of metformin…
DUBLIN–(BUSINESS WIRE)–The “CNS Therapeutics – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The global market…
DUBLIN–(BUSINESS WIRE)–The “2nd Annual Cell Therapy Bioprocessing Conference” conference has been added to ResearchAndMarkets.com’s offering. Over the last decade, the…
Data shows 14.8% women and 7.3% racial minorities on boards of UK life sciences companies LONDON–(BUSINESS WIRE)–#2020lifesciencesUK–A study of 132…
− Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten − Successful…
LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that KALYDECO® (ivacaftor) will be available to eligible patients with cystic fibrosis…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
– Analysis for the co-primary endpoint of objective response rate and an interim analysis of progression-free survival expected in the…